Ameriprise Financial Inc Kal Vista Pharmaceuticals, Inc. Transaction History
Ameriprise Financial Inc
- $388 Billion
- Q2 2025
A detailed history of Ameriprise Financial Inc transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 945,125 shares of KALV stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
945,125
Previous 40,072
2258.57%
Holding current value
$11.6 Million
Previous $462,000
2213.64%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding KALV
# of Institutions
146Shares Held
54.1MCall Options Held
986KPut Options Held
90.1K-
Vr Adviser, LLC New York, NY6.73MShares$82.4 Million15.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.96MShares$60.7 Million1.93% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$60.5 Million3.35% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$59.9 Million2.92% of portfolio
-
Vestal Point Capital, LP New York, NY4.68MShares$57.3 Million2.78% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $301M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...